{"id":"W3156170207","doi":"10.1016/j.ctarc.2021.100378","title":"RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis","year":2021,"lang":"en","type":"article","venue":"Cancer Treatment and Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Erlotinib; Ramucirumab; Internal medicine; Medicine; Placebo; Population; Oncology; Lung cancer; Subgroup analysis; Gastroenterology; Cancer; Epidermal growth factor receptor; Pathology; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002388569,0.001025268,0.001985467,0.0004111138,0.0001762379,0.0006659825,0.0005590732,0.0004695128,0.002415133],"category_scores_gemma":[0.001375961,0.0003848427,0.00350378,0.000399772,0.000326546,0.000509945,0.0003751195,0.0007896022,0.0003093648],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005759019,"about_ca_system_score_gemma":0.0005256956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006861257,"about_ca_topic_score_gemma":0.001765986,"domain_scores_codex":[0.9990435,0.0006649167,0.00006012429,0.0001021824,0.00005594529,0.00007318377],"domain_scores_gemma":[0.99934,0.0001883812,0.0002106766,0.00007122826,0.00005201999,0.000137725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9566326,0.00161076,0.01232179,0.0003776691,0.00945532,0.00009247996,0.0000696336,0.001191019,0.003160394,0.00008873225,0.001038405,0.01396118],"study_design_scores_gemma":[0.5373918,0.2837205,0.1321263,0.0001777723,0.03199907,0.0007424819,0.0002556847,0.005456795,0.003481707,0.0006092841,0.003953185,0.00008545307],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962218,0.001780084,0.0001982369,0.00008814039,0.00003498267,0.00029622,0.0007589432,0.00002561218,0.0005959813],"genre_scores_gemma":[0.9968394,0.0007387329,0.0002445747,0.0001663968,0.00005518357,0.0002838653,0.001104338,0.000006586289,0.0005610353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002415133,"threshold_uncertainty_score":0.01263207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06056040138403024,"score_gpt":0.4003621795605682,"score_spread":0.3398017781765379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}